rs121908931
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PM2_SupportingBS3_Supporting
This summary comes from the ClinGen Evidence Repository: The c.355G>A variant in COCH is a missense variant predicted to cause substitution of alanine by threonine at amino acid 119. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.394, which is neither above nor below the thresholds predicting a damaging or benign impact on COCH function. Functional studies show no differences between wild-type and p.A119T variant cochlin localization and secretion (BS3_Supporting). While this is not supporting evidence for pathogenicity, other mechanisms of pathogenicity cannot be ruled out. Due to conflicting evidence, this variant is classified as a variant of unknown significance for autosomal dominant nonsyndromic genetic deafness based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM2_P, BS3_P (Hearing Loss VCEP specifications version 2; 6/15/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA253893/MONDO:0019497/005
Frequency
Consequence
NM_004086.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461812Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727216
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 9 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 2003 | - - |
Nonsyndromic genetic hearing loss Uncertain:1
Uncertain significance, reviewed by expert panel | curation | ClinGen Hearing Loss Variant Curation Expert Panel | Jun 15, 2022 | The c.355G>A variant in COCH is a missense variant predicted to cause substitution of alanine by threonine at amino acid 119. This variant is absent from gnomAD v2.1.1 (PM2_Supporting). The computational predictor REVEL gives a score of 0.394, which is neither above nor below the thresholds predicting a damaging or benign impact on COCH function. Functional studies show no differences between wild-type and p.A119T variant cochlin localization and secretion (BS3_Supporting). While this is not supporting evidence for pathogenicity, other mechanisms of pathogenicity cannot be ruled out. Due to conflicting evidence, this variant is classified as a variant of unknown significance for autosomal dominant nonsyndromic genetic deafness based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM2_P, BS3_P (Hearing Loss VCEP specifications version 2; 6/15/2022). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at